CStone Pharmaceuticals (HKG:2616)

CStone Pharmaceuticals Statistics

Total Valuation

HKG:2616 has a market cap or net worth of HKD 12.27 billion. The enterprise value is 11.58 billion.

Market Cap	12.27B
Enterprise Value	11.58B

Important Dates

The last earnings date was Thursday, March 26, 2026.

Earnings Date	Mar 26, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2616 has 1.47 billion shares outstanding. The number of shares has increased by 10.46% in one year.

Current Share Class	1.47B
Shares Outstanding	1.47B
Shares Change (YoY)	+10.46%
Shares Change (QoQ)	+2.92%
Owned by Insiders (%)	1.65%
Owned by Institutions (%)	13.66%
Float	1.04B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	40.88
PB Ratio	17.87
P/TBV Ratio	23.60
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-23.82
EV / Sales	38.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.18, with a Debt / Equity ratio of 0.57.

Current Ratio	2.18
Quick Ratio	1.95
Debt / Equity	0.57
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-32.60

Financial Efficiency

Return on equity (ROE) is -89.13% and return on invested capital (ROIC) is -32.09%.

Return on Equity (ROE)	-89.13%
Return on Assets (ROA)	-19.65%
Return on Invested Capital (ROIC)	-32.09%
Return on Capital Employed (ROCE)	-51.01%
Weighted Average Cost of Capital (WACC)	7.46%
Revenue Per Employee	2.29M
Profits Per Employee	-3.71M
Employee Count	131
Asset Turnover	0.20
Inventory Turnover	1.08

Taxes

In the past 12 months, HKG:2616 has paid 14.54 million in taxes.

Income Tax	14.54M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +142.86% in the last 52 weeks. The beta is 0.61, so HKG:2616's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	+142.86%
50-Day Moving Average	6.17
200-Day Moving Average	6.64
Relative Strength Index (RSI)	70.00
Average Volume (20 Days)	17,275,345

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2616 had revenue of HKD 299.99 million and -486.30 million in losses. Loss per share was -0.34.

Revenue	299.99M
Gross Profit	57.03M
Operating Income	-481.43M
Pretax Income	-471.76M
Net Income	-486.30M
EBITDA	-466.63M
EBIT	-481.43M
Loss Per Share	-0.34

Balance Sheet

The company has 1.07 billion in cash and 387.83 million in debt, with a net cash position of 683.24 million or 0.46 per share.

Cash & Cash Equivalents	1.07B
Total Debt	387.83M
Net Cash	683.24M
Net Cash Per Share	0.46
Equity (Book Value)	686.35M
Book Value Per Share	0.46
Working Capital	670.99M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	15.07M
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 19.01%, with operating and profit margins of -160.48% and -162.10%.

Gross Margin	19.01%
Operating Margin	-160.48%
Pretax Margin	-157.26%
Profit Margin	-162.10%
EBITDA Margin	-155.55%
EBIT Margin	-160.48%
FCF Margin	n/a

Dividends & Yields

HKG:2616 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.46%
Shareholder Yield	-10.46%
Earnings Yield	-3.96%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4